Commission Regulation (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
L 118/28 EN Official Journal of the European Communities 6. 5. 1999 COMMISSION REGULATION (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, maximum residue limits always be established for muscle or fat tissues; should therefore also Having regard to the Treaty establishing the European Community, Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veter- inary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 953/ 1999 (2), and in particular Articles 7 and 8 thereof, (1) Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be estab- lished progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals; (2) Whereas maximum residue limits should be estab- lished only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs; the substance concerned for (3) Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue); (4) Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established fo the target tissues of liver or kidney; whereas, however, the liver and kidney are frequently removed from and carcases moving in international trade, (5) Whereas, in the case of veterinary medicinal pro- ducts intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey; (6) Whereas, in order to allow for the completion of scientific studies, cypermethrin, alphacypermethrin and cefquinome should be inserted into Annex III to Regulation (EEC) No 2377/90; (7) Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjust- ment which may be necessary to the authorisations to place veterinary medicinal products concerned on the market which have been granted in 81/ accordance with Council Directive 851/EEC (3), as last amended by Directive 93/ 40/EEC (4), to take account of the provisions of this Regulation; the (8) Whereas the measures provided for in this Regula- tion are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products, HAS ADOPTED THE FOLLOWING REGULATION: Article 1 Annex III to Regulation (EEC) No 2377/90 is hereby amended as set out in the Annex hereto. Article 2 This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities. (1) OJ L 224, 18. 8. 1990, p. 1. (2) See page 23 of this Official Journal. (3) OJ L 317, 6. 11. 1981, p. 1. (4) OJ L 214, 24. 8. 1993, p. 31. 6. 5. 1999 EN Official Journal of the European Communities L 118/29 This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 5 May 1999. For the Commission Martin BANGEMANN Member of the Commission Annex III to Regulation (EEC) No 2377/90 is amended as follows: ANNEX 1. Anti-infectious agents 1. 2. Antibiotics 1. 2. 4. Cephalosporins Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions ‘Cefquinome Cefquinome Porcine 50 lg/kg 50 lg/kg 100 lg/kg 200 lg/kg Muscle Skin + fat Liver Kidney Provisional MRLs expire on 1. 1. 2000' 2. Antiparasitic agents 2. 2. Agents acting against ectoparasites 2. 2. 3. Pyrethroids Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions ‘Alphacypermethrin Cypermethrin (sum of isomers) Bovine, ovine Chicken 20 lg/kg 200 lg/kg 20 lg/kg 20 lg/kg 20 lg/kg Muscle Fat Liver Kidney Milk Further provisions in Council Directive 93/57/EC (OJ L 211, 23. 8. 1992, p. 1) are to be observed 50 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg Muscle Skin + fat Liver Kidney Eggs Provisional MRLs expire on 1. 1. 2002 L 1 1 8 / 3 0 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 6. 5. 1 9 9 9 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Cypermethrin Cypermethrin (sum of isomers) Bovine, ovine, caprine Porcine Chicken Salmonidae Provisional MRLs expire on 1. 1. 2002' 20 lg/kg 200 lg/kg 20 lg/kg 20 lg/kg 20 lg/kg Muscle Fat Liver Kidney Milk Further provisions in Council Directive 93/57/EC (OJ L 211, 23. 8. 1992, p. 1) are to be observed Muscle Skin + fat Liver Kidney Muscle Skin + fat Liver Kidney Eggs Muscle and skin in natural proportions 20 lg/kg 200 lg/kg 20 lg/kg 20 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg 50 lg/kg 6. 5. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 1 1 8 / 3 1